Company profile for Yaopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

A manufacturer of finished-dosage-form pharmaceuticals, established in 1939. Oral solid production line passed Health Canada GMP inspection in Oct 2010.Key Products:1. Reduced Glutathione for Injection (annual sales in China: 25 million vials)Indications: 1) liver protection; 2) adjuvant in cancer chemotherapy2. Alprostadil Dried Emulsion for Injection (Prostaglandin E1, PGE1)Indications: Diabetic Vascular Diseases

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
100 Xingguang Avenue, Renhe Town, Yubei District
Telephone
Telephone
86 236 321 1443
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212201

FDA
07 Nov 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207219

FDA
20 Aug 2019

Drugs in Development

read-more
read-more

Details:

YP05002 is a drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Overweight.


Lead Product(s): YP05002

Therapeutic Area: Nutrition and Weight Loss Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 28, 2025

blank

01

Yaopharma

China
arrow
BIO Partnering at JPM
Not Confirmed

Yaopharma

China
arrow
BIO Partnering at JPM
Not Confirmed

Details : YP05002 is a drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Overweight.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

July 28, 2025

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Yaopharma and get a quotation

Yaopharma is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Clindamycin Palmitate bulk with DMF offered by Yaopharma

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty